Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Topic search: PEDIATRICS

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

 
Refine your search by entering keywords here:

Pediatrics Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounded "Monster Spray" for Nighttime Terrors: A Case Report
Riepl Mike
Nov/Dec 2023
Pg. 446-448

Calculations
Stockton Shelly J
Nov/Dec 2023
Pg. 488

Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Spennacchio Antonio
, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jan/Feb 2023
Pg. 72-77

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
May/Jun 2022
Pg. 233

Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
Jan/Feb 2022
Pg. 56

Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
Nov/Dec 2021
Pg. 506

Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 509

Calculations
Stockton Shelly J
Jul/Aug 2021
Pg. 318

Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 321

Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation
Odanaka Keita
, Kojima Hiroki, Nakagawa Naoto
May/Jun 2021
Pg. 258-262

Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 142

Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 144

Calculations
Stockton Shelly J
Jan/Feb 2021
Pg. 40

Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested
Dijkers Eli
, Polonini Hudson, de Oliveira Ferreira Anderson
Sep/Oct 2020
Pg. 408-412

Sorafenib Capsules for Pediatric Use
Allen Loyd V Jr
Sep/Oct 2019
Pg. 411

Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients
de Lafuente Yanina
, García Mónica Cristina, Jiminez-Kairuz Alvaro
Jul/Aug 2019
Pg. 324-331

Methotrexate 2-mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2019
Pg. 235

Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
Jan/Feb 2019
Pg. 35-44

PreScription: Standardized Concentrations: Pro or Con?
Allen Loyd V Jr
Nov/Dec 2018
Pg. 444

Current Trends and Emerging Priorities in Compounded Preparations for Children
Parrish Richard H II
Sep/Oct 2018
Pg. 358-366

Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes
Kirkham Kylian
, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Sep/Oct 2017
Pg. 426-429

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
Jul/Aug 2017
Pg. 282-289

Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules
Dijkers Eli
, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
Mar/Apr 2017
Pg. 171-175

Case Report: Pediatric Scar Management After Open-heart Surgery
Phan Ha
, Harger Beau, Estrada Nick
Jul/Aug 2016
Pg. 277-280

Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Nahata Milap C
May/Jun 2016
Pg. 247-249

Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A
, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2016
Pg. 257-261

Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
Jan/Feb 2016
Pg. 6-10

Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls
Gonzalez Mark
May/Jun 2015
Pg. 205-211

L-Cysteine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 146

Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Bourget Philippe
, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
Sep/Oct 2014
Pg. 427-431

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014
Pg. 6-12

Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2
Horace Alexis E
, Akbarian-Tefagh Jessica
Nov/Dec 2013
Pg. 446-450

Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms
McElhiney Linda F
Sep/Oct 2013
Pg. 364-368

Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1
Horace Alexis E
, Akbarian-Tefagh Jessica
Sep/Oct 2013
Pg. 388-391

Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 419

Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment
Aghahowa S E
, Egharevba J O, Erhagbe B E, Okoh F
Sep/Oct 2013
Pg. 432-435

Pediatric Health Care: An Introduction
Williams LaVonn A
Jan/Feb 2013
Pg. 6-8

A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A
, Allen Loyd V Jr
Jul/Aug 2012
Pg. 270-274

A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients
Nolan Sara M
, Burgess Christopher A
Nov/Dec 2011
Pg. 446-448

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Diaper Rash Relief: Common Sense Remedies and Treatments
Wiliams Kacee D
, Williams LaVonn
Nov/Dec 2011
Pg. 464-469

Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride
Zur Eyal
Sep/Oct 2011
Pg. 358-366

Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
Sep/Oct 2011
Pg. 386-387

Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient
Bramwell Bethany
Jul/Aug 2011
Pg. 316-319

Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
May/Jun 2011
Pg. 194-199

Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Wynn Tom
, Goetsch Daniel
May/Jun 2011
Pg. 200-203

Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay
, Williams LaVonn A
Mar/Apr 2011
Pg. 124-128

Acetylcysteine 1% or 10% Oral Solution
Allen Loyd V Jr
Mar/Apr 2011
Pg. 156

Glutathione 25% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 518

Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
Jul/Aug 2010
Pg. 270-274

Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F
, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010
Pg. 21-25

Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George
, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2010
Pg. 40-45

When Traditional Medicine Fails
Bash Robert
Jan/Feb 2010
Pg. 6-8

Calculations
Stockton Shelly J
Jan/Feb 2010
Pg. 58-59

Emanuel Butt Paste
Allen Loyd V Jr
Sep/Oct 2009
Pg. 431

Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L
, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2009
Pg. 314-317

Compounding Naltrexone for the Treatment of Autism
Wynn Tom
, Brunetti Sarah
Jul/Aug 2009
Pg. 296-299

Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report
Muller George
May/Jun 2009
Pg. 220-221

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R
, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jan/Feb 2009
Pg. 14-18

Calculations
Stockton Shelly J
Jan/Feb 2009
Pg. 63

Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets
Allen Loyd V Jr
Jan/Feb 2009
Pg. 64

Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder
Allen Loyd V Jr
Jan/Feb 2009
Pg. 65

Diaper Rash Cream with Miconazole
Allen Loyd V Jr
Jan/Feb 2009
Pg. 68

Diphenhydramine Hydrochloride 25-mg Gelatin Troches
Allen Loyd V Jr
Jan/Feb 2009
Pg. 69

Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia
, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008
Pg. 365-367

Benzyl Benzoate Lotion
Allen Loyd V Jr
May/Jun 2008
Pg. 261

Valsartan 4-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2008
Pg. 269

Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2008
Pg. 73

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007
Pg. 220-225

Methylphenidate 1-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 249

Challenges of Compounding for Patients on the Ketogenic Diet
McElhiney Linda F
Mar/Apr 2007
Pg. 116-120

Ranitidine Hydrochloride 15-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2007
Pg. 161

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007
Pg. 5-8

Principles of Pediatric Palliative Care and Pain Control
Peralta Alexander Jr
Jan/Feb 2007
Pg. 10-15

Pediatric Oral Formulations: A Continual Challenge
Hurtado Josephine
, Moffett Brady S
Jan/Feb 2007
Pg. 17-19

Sevelamer Suspension in Children with End-Stage Renal Disease
McElhiney Linda F
Jan/Feb 2007
Pg. 20-24

Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis
Fields Shannon W
Jan/Feb 2007
Pg. 26-27

Case Report: Treatment of Labial Adhesions in a Child
Fields Shannon W
Jan/Feb 2007
Pg. 27

Calculations
Stockton Shelly J
Jan/Feb 2007
Pg. 68

Caffeine Citrate 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 69

Carbidopa 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 70

Clonidine Hydrochloride 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 71

Methyldopa 25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 75

Metolazone 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 76

Prednisone 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 77

Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 78

Nitrazepam 1-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 388

Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Allen Loyd V Jr
Sep/Oct 2006
Pg. 390

Adderall 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 299

Lisinopril 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 302

Nifedipine 4-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 303

Propranolol Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 304

Propylthiouracil 5-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 67

Prescription: Pediatric Formulation Initiatives
Allen Loyd V Jr
Nov/Dec 2005
Pg. 410

Unlocking Autism: Is Compounding the Key?
Vail Jane
Nov/Dec 2005
Pg. 413-420

Compounding for a Pediatric Hospital
McElhiney Linda F
Nov/Dec 2005
Pg. 423-431

Wiping Out Diaper Rash
Fields Shannon W
Nov/Dec 2005
Pg. 433-434

View Sample
Pediatric Oral Liquid Preparations
Fonseca Simonne C
, Ferreira Anderson de O
Nov/Dec 2005
Pg. 437-442

Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
Nov/Dec 2005
Pg. 456-461

PostScription: Compounding Pharmacies and the Successful Treatment of Autism
Neurander James A
Nov/Dec 2005
Pg. 487-488

Calculations
Prince Shelly J
Jan/Feb 2005
Pg. 57

Stability of an Extemporaneously Compounded Propylthiouracil Suspension
Alexander Kenneth S
, Mitra Pallabi
Jan/Feb 2005
Pg. 82-86

A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
Nov/Dec 2004
Pg. 458-460

Domperidone in Lactation: Use as a Galactagogue
Albright Lisa M
Sep/Oct 2004
Pg. 329-335

Head to Toe Solutions: A Quick Review of Current Therapies
Paoletti James E
Sep/Oct 2004
Pg. 345-352

Book and Literature Reviews
Reed-Kane Dana
, Foy Elizabeth, MacCara Mary E
Jul/Aug 2004
Pg. 244-249

Gag Tablet Lollipops
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 184

Amiodarone HCl 5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2004
Pg. 214

Atenolol 2-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2004
Pg. 215

Glycopyrrolate 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2004
Pg. 218

Flucytosine 10-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 134

Griseofulvin 25-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 135

Stomatitis Mouthwash
Allen Loyd V Jr
Mar/Apr 2004
Pg. 140

Tacrolimus 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 141

Tiagabine 1-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2004
Pg. 142

Sulfasalazine 250-mg/5-mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2003
Pg. 474

Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension
Haase Mark R
, Khan Mansoor A, Bonilla Jeremiah
Nov/Dec 2003
Pg. 485-489

Thioridazine HCl 100-mg/mL Concentrated Solution
Allen Loyd V Jr
Sep/Oct 2003
Pg. 381

Isoniazid 10-mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2003
Pg. 376

Ursodiol 150-mg Capsules
Allen Loyd V Jr
Sep/Oct 2003
Pg. 382

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings
McElhiney Linda F
Sep/Oct 2003
Pg. 394-398

Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations
Okeke Claudia C
, Medwick Thomas, Nairn Graham, Shaila Khuspe, Grady Lee T
Jul/Aug 2003
Pg. 313-319

Pediatric Dermatitis
Remmert Renee
Nov/Dec 2002
Pg. 419-421

Excerpts from and Reviews of Current Published Literature: Pediatric Medications
Foy Elizabeth
, MacCara Mary E
Nov/Dec 2002
Pg. 423

Book Reviews: Compounding for Pediatric Patients
Ashworth Lisa D
, Reed-Kane Dana
Nov/Dec 2002
Pg. 424-425

Caffeine and Sodium Benzoate 250-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 449

Dimenhydrinate 50-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 451

Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2002
Pg. 367

Topical Secretin for the Treatment of Autism
King Erin
, Toney Steve
Nov/Dec 2001
Pg. 436-437

Basics of Compounding: Suspensions
Allen Loyd V Jr
Jul/Aug 2001
Pg. 294-297

Suspension Structured Vehicle, USP
Allen Loyd V Jr
Jul/Aug 2001
Pg. 296

Sugar-Free Suspension Structured Vehicle, USP
Allen Loyd V Jr
Jul/Aug 2001
Pg. 296

Spironolactone Oral Suspension 2-mg/mL
Allen Loyd V Jr
Jul/Aug 2001
Pg. 297

Progesterone Oral Suspension 40-mg/mL
Allen Loyd V Jr
Jul/Aug 2001
Pg. 297

Xanthan Gum Oral Suspension Vehicle 0.3%
Allen Loyd V Jr
Jul/Aug 2001
Pg. 297

Pediatric Preoperative Cocktail Injection
Allen Loyd V Jr
Jul/Aug 2001
Pg. 306

The Basics of Compounding Emulsions, Part 2
Allen Loyd V Jr
May/Jun 2001
Pg. 198-201

The Basics of Compounding Emulsions, Part 1
Allen Loyd V Jr
Mar/Apr 2001
Pg. 120-123

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
Jan/Feb 2001
Pg. 9-12

Flavoring: Compounding a Treat
Kloesel Lawson G
Jan/Feb 2001
Pg. 13-16

Autism in Children
Cave Stephanie
Jan/Feb 2001
Pg. 18-19

Methylphenidate in the Treatment of Attention Deficit Disorders
Tenreiro Kim
Jan/Feb 2001
Pg. 21-22

A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature
Foy Elizabeth
, MacCara Mary E
Jan/Feb 2001
Pg. 23-25

Compounding in History: Pediatric Considerations
Worthen Dennis B
Jan/Feb 2001
Pg. 30-31

Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations
Allen Loyd V Jr
Jan/Feb 2001
Pg. 38

Cholestyramine 6.5% Ointment
Allen Loyd V Jr
Jan/Feb 2001
Pg. 42

Ivermectin 0.8% Creme Rinse
Allen Loyd V Jr
Jan/Feb 2001
Pg. 43

Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel
Allen Loyd V Jr
Jan/Feb 2001
Pg. 44

Lorazepam 1-mg Chewable Gummy Gels
Allen Loyd V Jr
Jan/Feb 2001
Pg. 45

Metronidazole Benzoate 400-mg/5-mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2001
Pg. 46

Natural Head Lice Repellant Spray
Allen Loyd V Jr
Jan/Feb 2001
Pg. 48

Niacinamide 4% Acne Gel
Allen Loyd V Jr
Jan/Feb 2001
Pg. 49

Promethazine HCl 50-mg/mL in PLO Gel
Allen Loyd V Jr
Jan/Feb 2001
Pg. 51

Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations
Allen Loyd V Jr
Jul/Aug 2000
Pg. 289-293

Ondansetron HCl 8-mg/mL in PLO
Allen Loyd V Jr
Jul/Aug 2000
Pg. 305

Compounding Ear, Nose and Throat Preparations
Allen Loyd V Jr
May/Jun 2000
Pg. 164-169

Xylitol in the Prevention of Otitis Media
Glasnapp Andrew
May/Jun 2000
Pg. 171-174

Sildenafil 0.2% Otic Drops
Holland Robert T
, Quisling Richard
May/Jun 2000
Pg. 175

Amphotericin B 100-mg Troches
Allen Loyd V Jr
May/Jun 2000
Pg. 208

Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles
Allen Loyd V Jr
May/Jun 2000
Pg. 214

Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
Mar/Apr 2000
Pg. 122-125

Sugar-Free Suspension Structured Vehicle, USP
Allen Loyd V Jr
Mar/Apr 2000
Pg. 136

The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops
Allen Loyd V Jr
Nov/Dec 1999
Pg. 461-465

Linguet Base (Soft Lozenge)
Allen Loyd V Jr
Nov/Dec 1999
Pg. 462

Sorbitol Based Hard Lozenges
Allen Loyd V Jr
Nov/Dec 1999
Pg. 462

Sucrose Based Hard Lozenges
Allen Loyd V Jr
Nov/Dec 1999
Pg. 462

Polyethylene Glycol (PEG) Troches (Soft Lozenges)
Allen Loyd V Jr
Nov/Dec 1999
Pg. 463

Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges)
Allen Loyd V Jr
Nov/Dec 1999
Pg. 463

Chewable Lozenges
Allen Loyd V Jr
Nov/Dec 1999
Pg. 464

Methotrexate 2.5-mg/5-mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 1999
Pg. 474

Extemporaneous Formulations in Pediatric Patients
Nahata Milap C
Jul/Aug 1999
Pg. 274-276

Analysis of Extemporaneous Alprostadil Formulations
Sarver Jeffrey G
, Peng Ning, Lerdkanchanaporn Supaporn, Oravecz-Wilson Katherine, Alexander Kenneth S, Erhardt Paul W
Mar/Apr 1999
Pg. 148-155

Oral Ulceration Mouthwash
Allen Loyd V Jr
Jan/Feb 1999
Pg. 10

Alternatives for the Lactose-Intolerant Patient
Glasnapp Andrew
Nov/Dec 1998
Pg. 412

Pediatric Central Parenteral Nutrition Solution
Allen Loyd V Jr
Sep/Oct 1998
Pg. 368

Pediatric Central Parenteral Nutrition Solution with Heparin
Allen Loyd V Jr
Sep/Oct 1998
Pg. 369

Pediatric Peripheral Parenteral Nutrition Solution
Allen Loyd V Jr
Sep/Oct 1998
Pg. 370

Malathion Topical Lotion: Therapy for Resistant Head Lice
Glasnapp Andrew
, Nguyen Linh
Jul/Aug 1998
Pg. 268-269

Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration
Inagaki Kazuhiro
, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio
Jul/Aug 1998
Pg. 318-321

Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel
Allen Loyd V Jr
Mar/Apr 1998
Pg. 159

Vehicles for Compounding Oral Liquids: Some Practical Considerations
Palmer Henry A
Mar/Apr 1998
Pg. 160-161

Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane
Tenjarla Srini N
, Ward Earl S, Fox Janet L
Jan/Feb 1998
Pg. 83-88

Ketoconazole 20-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 1997
Pg. 414

Baclofen 10-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 1997
Pg. 321

Captopril 0.75-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 1997
Pg. 322

Diltiazem HCl 12-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 1997
Pg. 323

Stability of Bethanechol Chloride Oral Liquid Dosage Forms
Gupta Vishnu D
, Maswoswe J
Jul/Aug 1997
Pg. 278-279

Allopurinol 20-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 174

Dipyridamole 10-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 176

Labetalol HCl 40-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 179

Metoprolol Tartrate 10-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 180

Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 183

Spironolactone 25-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 184

Verapamil HCl 50-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 188

The Formulation Development and Stability of Spironolactone Suspension
Alexander Kenneth S
, Vangala Shyam Sundar KS, White Donald B, Dollimore David
May/Jun 1997
Pg. 195-199

The Formulation Development and Stability of Metronidazole Suspension
Alexander Kenneth S
, Vangala Shyam Sundar KS, Dollimore David
May/Jun 1997
Pg. 200-205

Metronidazole 15-mg/mL Suspension
Gupta Vishnu D
, Maswoswe J, Bailey RE
May/Jun 1997
Pg. 202

Compounding for the Pediatric Patient
Allen Loyd V Jr
Mar/Apr 1997
Pg. 84-86

Attention Deficit Hyperactivity Disorder
Allen Loyd V Jr
Mar/Apr 1997
Pg. 87-89

Flavors and Flavoring
Allen Loyd V Jr
Mar/Apr 1997
Pg. 90-92

Compounded Suppositories and Pharmaceutical Care
Duncan-Hewitt Wendy
, Rains John
Mar/Apr 1997
Pg. 93-99

Acetazolamide 25-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 101

Azathioprine 50-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 102

Flecainide Acetate 20-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 103

Methylcellulose 1% to 5% Solutions
Allen Loyd V Jr
Mar/Apr 1997
Pg. 104

Methylcellulose Oral-Liquid Vehicles
Allen Loyd V Jr
Mar/Apr 1997
Pg. 105

Pediatric Chewable Gummy Gel Base
Allen Loyd V Jr
Mar/Apr 1997
Pg. 106

Pediatric Chocolate Troche Base
Allen Loyd V Jr
Mar/Apr 1997
Pg. 106

Pediatric Chewable Gummy Gels
Allen Loyd V Jr
Mar/Apr 1997
Pg. 107

Pediatric Chocolate Troche
Allen Loyd V Jr
Mar/Apr 1997
Pg. 108

Nystatin Popsicles
Allen Loyd V Jr
Mar/Apr 1997
Pg. 109

Procainamide HCl 50-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 1997
Pg. 110

Syrup NF
Allen Loyd V Jr
Mar/Apr 1997
Pg. 111

Tetracaine 20-mg Lollipops
Allen Loyd V Jr
Mar/Apr 1997
Pg. 112

Tetracycline Compound Troche
Allen Loyd V Jr
Mar/Apr 1997
Pg. 113

Xanthan Gum Suspension Vehicle (0.2% to 0.5%)
Allen Loyd V Jr
Mar/Apr 1997
Pg. 114

Omeprazole (Prilosec) in the Atypical Patient, Administration of
Kane Dana Lynn
Jan/Feb 1997
Pg. 13

HDDM Hard Troche
Allen Loyd V Jr
Jan/Feb 1997
Pg. 29

HDDM Soft Troche
Allen Loyd V Jr
Jan/Feb 1997
Pg. 30

HDDM Sugar Troche
Allen Loyd V Jr
Jan/Feb 1997
Pg. 30

Metoclophen Nausea Suppositories
Allen Loyd V Jr
Jan/Feb 1997
Pg. 31

Metoclophen-Modified Nausea Suppositories
Allen Loyd V Jr
Jan/Feb 1997
Pg. 31

Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets
Alexander Kenneth S
, Kothapalli Madhu R, Dollimor David
Jan/Feb 1997
Pg. 60-63

Return to Top